Power Law company profile

Concert Pharmaceuticals

Biotech & Life Sciences · Lexington, United States · Founded 2006 · IPO 2014 Thoroughbred

Concert Home Page - Concert Pharmaceuticals

Valuation

$267M

Market cap · 2026

Revenue

$32M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Concert Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

GSK

Series B+ 1 investor entered at this stage

Flagship Pioneering

Global footprint

Where Concert Pharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Lexington HQ

Book a demo for the full country breakdown

Market sentiment

What the market is saying about Concert Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Concert Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Concert Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles